Related Experiment Video
Updated: Sep 24, 2025
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
43.0K
SARS-CoV-2 variants - Evolution, spike protein, and vaccines
Kai-Wei K Chen1, Daniel Tsung-Ning Huang2, Li-Min Huang3
1Department of Pediatrics, MacKay Children's Hospital, Taipei, Taiwan.
Biomedical Journal
|May 8, 2022
Summary
The emergence of SARS-CoV-2 variants like Omicron has led to COVID-19 resurgence despite immunity. This review examines variant evolution, features, and vaccine strategies to control the pandemic.
Area of Science:
- Virology
- Epidemiology
- Immunology
Background:
- Despite widespread immunity, COVID-19 resurgence is observed globally.
- Emergence of SARS-CoV-2 variants of concern (VOCs) like Alpha and Omicron drives this resurgence.
- Spike protein mutations in VOCs affect virus transmissibility and antigenicity.
Purpose of the Study:
- To review the evolutionary trajectory of SARS-CoV-2.
- To summarize epidemiological and clinical characteristics of SARS-CoV-2 variants.
- To discuss vaccine-based strategies for mitigating COVID-19.
Main Methods:
- Literature review of SARS-CoV-2 evolution.
- Synthesis of current data on variant epidemiology and clinical presentation.
- Analysis of vaccine response strategies against VOCs.
Main Results:
- Detailed account of SARS-CoV-2 evolution from early strains to Omicron.
- Summary of key epidemiological trends and clinical outcomes associated with major variants.
- Assessment of vaccine effectiveness and potential modifications.
Conclusions:
- SARS-CoV-2 variants pose an ongoing threat, necessitating continuous monitoring.
- Understanding variant characteristics is crucial for effective public health interventions.
- Vaccine strategies must adapt to combat evolving SARS-CoV-2 strains and reduce disease burden.
More Related Videos
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.4K
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.9K
Related Concept Videos
00:36Viral Mutations
33.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.6K
01:05Single Nucleotide Polymorphisms-SNPs
16.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.1K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K
02:50Conjugated Proteins
18.6K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.6K
00:57Viral Recombination
23.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.9K
01:29Viruses with RNA Genomes
169
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
169